Metabiomics Colon Cancer Clinical Research Study
| Status: | Not yet recruiting |
|---|---|
| Conditions: | Colorectal Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - 95 |
| Updated: | 8/17/2018 |
| Start Date: | March 2019 |
| End Date: | September 2020 |
| Contact: | Tracey MacDermott |
| Email: | tracey.macdermott@ucdenver.edu |
| Phone: | 303-724-2757 |
The specific aim of the study is to determine the false negative rate of the Metabiomics
Colon Polyp and Colorectal Cancer Assay for Cancer.
Colon Polyp and Colorectal Cancer Assay for Cancer.
The purpose of this study is to conduct clinical research to investigate the association of
the gut microbiome with colonic neoplasia. In this case several types of gut microbiome
samples will be collected from patients undergoing colectomy for colonic adenocarcinoma;
those samples will be tested by Metabiomics Colon Polyp and Colorectal Cancer Assay and the
percentage of false negative (test returns a negative for cancer) results determined.
the gut microbiome with colonic neoplasia. In this case several types of gut microbiome
samples will be collected from patients undergoing colectomy for colonic adenocarcinoma;
those samples will be tested by Metabiomics Colon Polyp and Colorectal Cancer Assay and the
percentage of false negative (test returns a negative for cancer) results determined.
Inclusion Criteria:
- Recently diagnosed with colorectal cancer (CRC) and scheduled for colectomy
- Male or female,
- Age: 18-95 years,
- Able to comprehend, sign, and date the written informed consent form (ICF),
- Able to give informed consent in English
- Women and minorities will be included.
Exclusion Criteria:
- History of Inflammatory Bowel Disease
- Antibiotics within 2 weeks of sample collection.
- Colonoscopy, colon prep or bowel contrast agent within 7 days prior to sample
collection
- Any radiation therapy
We found this trial at
1
site
Click here to add this to my saved trials
